Urology
Volume 54, Issue 6 , Pages 968-971 , December 1999

Post-treatment PSA ≤0.2 ng/ml defines disease freedom after radiotherapy for prostate cancer using modern techniques

  • Frank A Critz

      Affiliations

    • Radiotherapy Clinics of Georgia, Decatur, Georgia, USA
    • Corresponding Author InformationReprint requests: Frank A. Critz, M.D., 2349 Lawrenceville Highway, Decatur, GA 30033
    • ,
  • W.Hamilton Williams

      Affiliations

    • Radiotherapy Clinics of Georgia, Decatur, Georgia, USA
    • ,
  • Clinton T Holladay

      Affiliations

    • Radiotherapy Clinics of Georgia, Decatur, Georgia, USA
    • ,
  • A.Keith Levinson

      Affiliations

    • Georgia Urology, Decatur, Georgia, USA
    • ,
  • James B Benton

      Affiliations

    • Radiotherapy Clinics of Georgia, Decatur, Georgia, USA
    • ,
  • David A Holladay

      Affiliations

    • Radiotherapy Clinics of Georgia, Decatur, Georgia, USA
    • ,
  • Frederick J Schnell Jr

      Affiliations

    • Radiotherapy Clinics of Georgia, Decatur, Georgia, USA
    • ,
  • Leela S Maxa

      Affiliations

    • Radiotherapy Clinics of Georgia, Decatur, Georgia, USA
    • ,
  • Philip D Shrake

      Affiliations

    • Radiotherapy Clinics of Georgia, Decatur, Georgia, USA

Received 15 June 1999 ,Revised 20 July 1999 ,Accepted 20 July 1999.

References 

  1. Kupelian P, Katcher J, Zippe C, et al.  External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer (therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores). Cancer J Sci Am. 1997;3:78–87
  2. Consensus Statement: guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 37: 1035–1041, 1997.
  3. Fukunaga-Johnson N, Sandler HM, McLaughlin PW, et al.  Results of 3D conformal radiotherapy in the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys. 1997;38:311–317
  4. Hanks GE, Hanlon AL, Schultheiss TE, et al.  Dose escalation with 3D conformal treatment (five year outcomes, treatment optimization, and future directions). Int J Radiat Oncol Biol Phys. 1998;41:501–510
  5. Stock RG, Stone NN, DeWyngaert JK, et al.  Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma. Cancer. 1996;77:2386–2392
  6. Critz FA, Levinson AK, Williams WH, et al.  Prostate specific antigen nadir (the optimum level after irradiation for prostate cancer). J Clin Oncol. 1996;14:2893–2900
  7. McLaughlin PW, Sandler HM, Jiroutek MR. Prostate-specific antigen following prostate radiotherapy (how low can you go?). J Clin Oncol. 1996;14:2889–2892
  8. Crook JM, Bahadur YA, Bociek RG, et al.  Radiotherapy for localized prostate carcinoma. Cancer. 1997;79:328–336
  9. Slater JD, Yonemoto LT, Rossi CJ, et al.  Conformal proton therapy for prostate carcinoma. Int J Radiat Oncol Biol Phys. 1998;42:299–304
  10. Storey MR, Landgen RC, Cottone JL, et al.  Transperineal 125 iodine implantation for treatment of clinically localized prostate cancer (5-year tumor control and morbidity). Int J Radiat Oncol Biol Phys. 1999;43:565–570
  11. Grado GL, Larson TR, Balch CS, et al.  Actuarial disease-free survival after prostate cancer brachytherapy using interactive techniques with biplane ultrasound and fluoroscopic guidance. Int J Radiat Oncol Biol Phys. 1998;42:289–299
  12. Critz FA, Levinson AK, Williams WH, et al.  Prostate specific antigen nadir achieved by men apparently cured of prostate cancer by radiotherapy. J Urol. 1999;161:1199–1205
  13. Pound CR, Partin AW, Epstein JI, et al.  Prostate-specific antigen after anatomic radical retropubic prostatectomy. Urol Clin North Am. 1997;24:395–406
  14. Vicini FA, Horowiz EM, Gonzalez J, et al.  Treatment options for localized cancer based on pretreatment serum prostate specific antigen levels. J Urol. 1997;158:319–325
  15. Catalona WJ, Smith DS. Cancer recurrence and survival rates after intermediate-term results. J Urol. 1998;160:2428–2434

PII: S0090-4295(99)00346-5

Urology
Volume 54, Issue 6 , Pages 968-971 , December 1999

Article Tools

* Image Usage & Resolution